Cynosure Group’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$407K Buy
18,777
+3,408
+22% +$74K 0.05% 279
2025
Q1
$373K Buy
15,369
+1,321
+9% +$32K 0.05% 186
2024
Q4
$293K Sell
14,048
-3,688
-21% -$77K 0.04% 279
2024
Q3
$353K Buy
+17,736
New +$353K 0.05% 340